Tango Therapeutics (TNGX) News Today → Breaking - The US Gov. Seized CITGO (From Augury Research) (Ad) Free TNGX Stock Alerts $6.90 -0.30 (-4.17%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 11:24 PM | marketbeat.comRTW Investments LP Purchases Shares of 1,966,752 Tango Therapeutics, Inc. (NASDAQ:TNGX)RTW Investments LP purchased a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,966,752 shares of the company's stock, valued at approximately $19,June 7 at 10:24 PM | marketbeat.comInsider Selling: Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells 63,000 Shares of StockTango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Mva Investors, Llc sold 63,000 shares of the firm's stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $7.24, for a total transaction of $456,120.00. Following the completion of the transaction, the insider now directly owns 420,524 shares in the company, valued at $3,044,593.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.June 5 at 7:00 AM | businesswire.comTango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceMay 31, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Trading Up 6.8%Tango Therapeutics (NASDAQ:TNGX) Shares Up 6.8%May 30, 2024 | americanbankingnews.comHC Wainwright Weighs in on Tango Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:TNGX)May 29, 2024 | americanbankingnews.comTango Therapeutics (NASDAQ:TNGX) Price Target Cut to $13.00 by Analysts at HC WainwrightMay 28, 2024 | marketbeat.comHC Wainwright Trims Tango Therapeutics (NASDAQ:TNGX) Target Price to $13.00HC Wainwright reduced their price target on Tango Therapeutics from $16.00 to $13.00 and set a "buy" rating for the company in a report on Tuesday.May 27, 2024 | marketbeat.comTango Therapeutics, Inc. Forecasted to Post Q2 2024 Earnings of ($0.29) Per Share (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Equities researchers at Wedbush increased their Q2 2024 EPS estimates for Tango Therapeutics in a research report issued on Thursday, May 23rd. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.29) per share for the quaMay 24, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Price Target Cut to $14.00Guggenheim decreased their price objective on shares of Tango Therapeutics from $16.00 to $14.00 and set a "buy" rating for the company in a report on Friday.May 24, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Buy" by AnalystsShares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) have earned an average recommendation of "Buy" from the six analysts that are covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price objective amongMay 23, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Medtronic (MDT), Crispr Therapeutics AG (CRSP) and Tango Therapeutics (TNGX)May 23, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Down After Analyst DowngradeTango Therapeutics (NASDAQ:TNGX) Shares Gap Down Following Analyst DowngradeMay 23, 2024 | prnewswire.comMedivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical programMay 23, 2024 | reuters.comTango Therapeutics to stop development of cancer therapyMay 23, 2024 | businesswire.comTango Therapeutics Announces Discontinuation of TNG348 ProgramMay 17, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Down 3.7% Tango Therapeutics (NASDAQ:TNGX) Trading Down 3.7%May 10, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Trading Down 7.3%Tango Therapeutics (NASDAQ:TNGX) Shares Down 7.3%May 10, 2024 | marketbeat.comFisher Asset Management LLC Takes Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)Fisher Asset Management LLC purchased a new stake in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 100,691 shares of the company's stock, valued at approximMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Tango Therapeutics on Promising PRMT5 Inhibitors and Strong FinancialsMay 9, 2024 | marketbeat.comTango Therapeutics' (TNGX) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $17.00 price target on shares of Tango Therapeutics in a research report on Thursday.May 8, 2024 | investorplace.comTNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | businesswire.comTango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business HighlightsMay 4, 2024 | insidertrades.comInsider Selling: Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells 60,000 Shares of StockMay 3, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells $456,600.00 in StockTango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Mva Investors, Llc sold 60,000 shares of Tango Therapeutics stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $7.61, for a total transaction of $456,600.00. Following the sale, the insider now owns 483,524 shares in the company, valued at approximately $3,679,617.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.April 25, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Down 7%Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 7%April 19, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Down 3.8%Tango Therapeutics (NASDAQ:TNGX) Shares Down 3.8%April 18, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Expected to Post Q2 2024 Earnings of ($0.34) Per ShareTango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Investment analysts at B. Riley issued their Q2 2024 earnings per share (EPS) estimates for shares of Tango Therapeutics in a report issued on Monday, April 15th. B. Riley analyst Y. Zhi expects that the company will earn ($0.34) per share foApril 17, 2024 | marketbeat.comTango Therapeutics, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.33) Per Share (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Investment analysts at B. Riley issued their Q1 2024 earnings estimates for Tango Therapeutics in a report issued on Monday, April 15th. B. Riley analyst Y. Zhi forecasts that the company will post earnings of ($0.33) per share for the quarteApril 12, 2024 | marketbeat.comFY2024 Earnings Estimate for Tango Therapeutics, Inc. Issued By Cantor Fitzgerald (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Cantor Fitzgerald issued their FY2024 earnings per share estimates for Tango Therapeutics in a research note issued on Tuesday, April 9th. Cantor Fitzgerald analyst E. Schmidt expects that the company will post earnings of ($1.28) per share fApril 12, 2024 | marketbeat.comVanguard Group Inc. Purchases 197,624 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX)Vanguard Group Inc. lifted its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 7.2% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,939,843 shares of the company's stock after acquiring an additional 197,624 shares during tApril 5, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Down 3.3% Tango Therapeutics (NASDAQ:TNGX) Trading Down 3.3%April 4, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Up 5.2%Tango Therapeutics (NASDAQ:TNGX) Trading Up 5.2%April 4, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Earns Overweight Rating from Analysts at Cantor FitzgeraldCantor Fitzgerald initiated coverage on Tango Therapeutics in a research note on Thursday. They issued an "overweight" rating for the company.April 1, 2024 | businesswire.comTango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 21, 2024 | markets.businessinsider.comBuy Rating Affirmed for Tango Therapeutics on Strong Pipeline and Financial StabilityMarch 21, 2024 | marketbeat.comQ1 2024 Earnings Forecast for Tango Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:TNGX)Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) - Equities research analysts at Leerink Partnrs decreased their Q1 2024 earnings estimates for shares of Tango Therapeutics in a research note issued on Monday, March 18th. Leerink Partnrs analyst A. Berens now forecasts that the company will pMarch 20, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Up After Analyst UpgradeTango Therapeutics (NASDAQ:TNGX) Shares Gap Up Following Analyst UpgradeMarch 20, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) PT Raised to $17.00 at HC WainwrightHC Wainwright boosted their target price on Tango Therapeutics from $16.00 to $17.00 and gave the company a "buy" rating in a research report on Wednesday.March 20, 2024 | finance.yahoo.comTango Therapeutics Inc (TNGX) Reports Full Year and Q4 2023 Financial ResultsMarch 18, 2024 | marketbeat.comWedbush Reaffirms "Outperform" Rating for Tango Therapeutics (NASDAQ:TNGX)Wedbush reiterated an "outperform" rating and issued a $18.00 target price on shares of Tango Therapeutics in a research note on Monday.March 18, 2024 | investorplace.comTNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023March 18, 2024 | benzinga.comRecap: Tango Therapeutics Q4 EarningsMarch 18, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Down to $9.03Tango Therapeutics (NASDAQ:TNGX) Shares Gap Down to $9.03March 12, 2024 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Down 6% Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 6%March 11, 2024 | finance.yahoo.comTNGX Aug 2024 20.000 putMarch 9, 2024 | marketbeat.comInvesco Ltd. Has $8.72 Million Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)Invesco Ltd. increased its position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 3,247.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 774,738 shares of the company's stock after purchaMarch 8, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Increases Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)Adage Capital Partners GP L.L.C. boosted its stake in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 47.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,754,852 shares ofMarch 8, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Boosts Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)Adage Capital Partners GP L.L.C. raised its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 47.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,754,852 shares of the company's stock after purchasMarch 6, 2024 | businesswire.comTango Therapeutics to Participate in Upcoming Investor ConferencesMarch 6, 2024 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 205.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 367,357 shares of the company's stock after purchasing a Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address After Conviction, More Bad News for Trump (Ad)As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown. Click here to see the details because this coming election meltdown could trigger… TNGX Media Mentions By Week TNGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNGX News Sentiment▼0.130.73▲Average Medical News Sentiment TNGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNGX Articles This Week▼42▲TNGX Articles Average Week Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OUST News Today CMPO News Today DCGO News Today QSI News Today PRCH News Today ORGN News Today EOSE News Today LTCH News Today MNTS News Today FOLD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNGX) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredNvidia has Apple and Microsoft within striking rangeA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. W...Weiss Ratings | Sponsored